Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Journal of the American Pharmacists Association : Japha|October 20, 2020
Understanding Oregon's Public Health and Pharmacy Formulary Advisory CommitteeCrystal F Sharp, Kevin E Russell, Adriane N Irwin
Pain Medicine (Malden, Mass.)|October 11, 2020
Exploring Patient Perceptions of Opioid Treatment Agreements in a Community Health Center EnvironmentAdriane N Irwin, Natalea Braden-Suchy, Daniel M Hartung
Journal of the American Pharmacists Association : Japha|July 19, 2020
Pharmacist experiences and perspectives with Oregon's Death with Dignity ActKatherine A Peters, David S Lee, Adriane N Irwin
Pharmacotherapy|July 26, 2018
FDA Breakthrough Therapy Designation: Evaluating the Quality of the Evidence behind the Drug ApprovalsMegan C Herink, Adriane N Irwin, Gregory M Zumach
Journal of the American Pharmacists Association : Japha|December 15, 2020
Understanding barriers to prescription retrieval and attitudes toward mental health medications at a university student health services pharmacyNatasha M Malik, Jennifer L Davis, Adriane N Irwin
Journal of the American Pharmacists Association : Japha|April 24, 2019
Development of a pharmacist-provided contraceptive service following passage of Oregon House Bill 2879Sylvia Walsh, Adriane N Irwin, Lorinda Anderson, et al.
Research in Social & Administrative Pharmacy : RSAP|December 15, 2017
Accuracy of medication histories collected by pharmacy technicians during hospital admissionJena Jobin, Adriane N Irwin, Jana Pimentel, et al.
Pharmacotherapy|March 27, 2015
Labor costs and economic impact of a primary care clinical pharmacy service on postfracture care in postmenopausal womenAdriane N Irwin, Sarah J Billups, Rachel M F Heilmann
Pharmacotherapy|June 8, 2013
Assessment of warfarin dosing requirements after bariatric surgery in patients requiring long-term warfarin therapyAdriane N Irwin, Kathleen H McCool, Thomas Delate, et al.
Pharmacy (Basel, Switzerland)|October 26, 2022
Pharmacists' Knowledge and Perceptions of FDA Approval Standards and the Breakthrough Therapy DesignationMegan C Herink, Kirbee Johnston, Kristin Breninger, et al.
Pageof 5